Felice, Carla
 Distribuzione geografica
Continente #
EU - Europa 1.097
NA - Nord America 1.008
AS - Asia 354
SA - Sud America 56
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.524
Nazione #
US - Stati Uniti d'America 995
DE - Germania 525
CN - Cina 150
SE - Svezia 139
SG - Singapore 112
UA - Ucraina 92
IT - Italia 81
FR - Francia 74
GB - Regno Unito 59
BR - Brasile 53
IE - Irlanda 35
FI - Finlandia 29
IN - India 29
ID - Indonesia 26
RU - Federazione Russa 19
BE - Belgio 12
CA - Canada 11
TR - Turchia 10
NL - Olanda 8
IR - Iran 6
PL - Polonia 5
JP - Giappone 4
KR - Corea 4
AT - Austria 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
AR - Argentina 2
BD - Bangladesh 2
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
PH - Filippine 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
CG - Congo 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
OM - Oman 1
RO - Romania 1
SC - Seychelles 1
TN - Tunisia 1
TW - Taiwan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.524
Città #
Chandler 227
Ashburn 90
Singapore 85
Jacksonville 79
San Mateo 50
Dearborn 47
New York 39
Ann Arbor 38
Nürnberg 37
Dublin 34
Cattolica 30
Nanjing 28
Jakarta 25
Wilmington 24
Munich 21
Milan 20
Bremen 17
Boston 16
Beijing 14
Lawrence 14
Brussels 12
Houston 12
Lancaster 11
Los Angeles 11
Helsinki 10
Izmir 9
Moscow 9
Princeton 9
Leawood 8
Nanchang 8
Seattle 8
Detroit 7
Düsseldorf 7
Frankfurt am Main 7
Hefei 7
Jiaxing 7
London 7
Redwood City 7
Rome 7
Toronto 7
Marseille 6
Mountain View 6
Shanghai 6
Shenyang 6
Boardman 5
Changsha 5
Hebei 5
São Paulo 5
Woodbridge 5
Andover 4
Ardabil 4
Fairfield 4
Redmond 4
San Francisco 4
Seoul 4
Tianjin 4
Abidjan 3
Amsterdam 3
Augusta 3
Costa Mesa 3
Edinburgh 3
Guangzhou 3
Jinan 3
Kunming 3
Simi Valley 3
Sofia 3
Washington 3
A Coruña 2
Appignano 2
Athens 2
Belo Horizonte 2
Berlin 2
Brasília 2
Changchun 2
Fremont 2
Hangzhou 2
Kish 2
Kraków 2
Lauterbourg 2
Lisbon 2
Manila 2
Millbury 2
Mumbai 2
Napoli 2
Norwalk 2
Nuremberg 2
Paris 2
Phoenix 2
Portsmouth 2
Praia Grande 2
Pune 2
Raritan 2
Stockholm 2
São Roque 2
Tappahannock 2
The Dalles 2
University Park 2
Vienna 2
Warsaw 2
Americana 1
Totale 1.280
Nome #
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 162
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 155
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 153
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 150
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 147
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 144
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 144
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 127
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 125
Use of infliximab in particular clinical settings: management based on current evidence. 113
Ileal Crohn's disease: CEUS determination of activity 113
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 105
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 96
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 87
Management of perianal fistulas in Crohn's disease: an up-to-date review 86
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 84
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 78
AID in aging and autoimmune diseases 77
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 75
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 70
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 58
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 56
Biological therapies for inflammatory bowel disease: controversies and future options 55
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 37
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 32
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 14
Totale 2.543
Categoria #
all - tutte 9.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021178 5 20 3 23 23 4 16 9 24 2 40 9
2021/2022237 27 17 4 39 4 3 3 47 7 4 30 52
2022/2023528 71 73 33 103 33 63 17 40 68 2 15 10
2023/2024244 10 50 6 20 3 50 3 33 10 12 24 23
2024/2025391 5 18 49 11 61 15 18 28 52 49 82 3
Totale 2.543